| Literature DB >> 21833741 |
Carolina H Y Ling1, Anton J M de Craen, P Eline Slagboom, Rudi G J Westendorp, Andrea B Maier.
Abstract
Low handgrip strength has been linked with premature mortality in diverse samples of middle-aged and elderly subjects. The value of handgrip strength as marker of "exceptional" human longevity has not been previously explored. We postulated that the genetic influence on extreme survival might also be involved in the muscular strength determination pathway. Therefore, the objective of this study was to assess the muscle strength in a sample of middle-aged adults who are genetically enriched for exceptional survival and comparing them to a control group. We included 336 offspring of the nonagenarian from the Leiden Longevity Study who were enriched for heritable exceptional longevity, and 336 of their partners were used as controls. The Leiden Longevity study was a prospective follow up study of long-living siblings pairs together with their offspring and their partners. Handgrip strength was used as a proxy for overall muscle strength. No significant difference in handgrip strength was seen between the offspring of the nonagenarian and their partners after adjustment for potential confounders including body compositions, sum score of comorbidities, medication use, smoking and alcohol history. The main determinants of midlife handgrip strength were age, gender, total body percentage fat and relative appendicular lean mass. Although midlife handgrip strength has previously been shown to be an important prognostic indicator of survival, it is not a marker of exceptional familial longevity in middle-aged adults. This finding suggests that genetic component of susceptibility to extreme survival is likely to be separate from that of muscular strength.Entities:
Mesh:
Year: 2011 PMID: 21833741 PMCID: PMC3448992 DOI: 10.1007/s11357-011-9295-4
Source DB: PubMed Journal: Age (Dordr) ISSN: 0161-9152
Baseline clinical characteristics of the offspring vs. partners of the offspring according to gender
| Variables | Female ( | Male ( | ||
|---|---|---|---|---|
| Offspring ( | Partners ( | Offspring ( | Partners ( | |
| Age, years (mean, SD) | 62.9 (5.9) | 60.7 (6.9) | 63.6 (6.0) | 65.4 (6.9) |
| Comorbidities (%) | 34.1 | 42.1 | 37.3 | 46.3 |
| Myocardial infarct | 0.0 | 1.2 | 2.4 | 6.1 |
| Stroke | 0.7 | 2.4 | 4.3 | 3.0 |
| Hypertension | 27.8 | 31.1 | 24.8 | 30.5 |
| Diabetes mellitus | 3.1 | 6.7 | 4.9 | 14.6 |
| Neoplasm | 6.8 | 8.5 | 7.3 | 7.0 |
| Chronic obstructive pulmonary disease | 2.3 | 4.2 | 6.7 | 3.1 |
| Rheumatoid arthritis | 0.7 | 1.2 | 0.6 | 1.5 |
| Sum score of comorbidities (median, IQR) | 0 (0–1) | 0 (0–1) | 0 (0–1) | 0 (0–1) |
| Medication categories (%) | ||||
| Cardiovascular | 30.9 | 31.2 | 24.6 | 46.7 |
| Anti-thrombotic | 5.1 | 6.5 | 10.5 | 18.5 |
| Chronic obstructive pulmonary disease | 5.1 | 5.9 | 4.1 | 1.5 |
| Anti-diabetics | 2.2 | 4.7 | 3.5 | 10.4 |
| Other endocrine medications | 8.1 | 5.9 | 0.6 | 2.2 |
| Nervous system | 19.9 | 14.7 | 9.4 | 12.6 |
| Sum score of medication categories (median, IQR) | 0 (0–1) | 0 (0–1) | 0 (0–1) | 1 (0–2) |
| Current smoking (%) | 7.4 | 15.6 | 13.8 | 13.1 |
| Excessive alcohol use (%) | 12.8 | 16.1 | 27.5 | 30.1 |
| Thyroid function | ||||
| TSH, mU/l (median, IQR) | 1.8 (1.1–2.7) | 1.6 (1.1–2.3) | 1.6 (1.2–2.1) | 1.5 (1.1–2.1) |
| fT3, pmol/l (mean, SD) | 3.9 (0.7) | 4.0 (0.7) | 4.3 (0.7) | 4.2 (0.6) |
| fT4, pmol/l (mean, SD) | 15.3 (2.5z) | 15.0 (2.6) | 15.5 (2.3) | 15.6 (1.9) |
Body compositions and handgrip strength measurements of the offspring vs. partners of the offspring according to gender
| Female ( |
| Male ( |
| |||
|---|---|---|---|---|---|---|
| Offspring ( | Partners ( | Offspring ( | Partners ( | |||
| Anthropometrical measurements | ||||||
| Height (cm) | 165.4 (0.5) | 166.4 (0.4) | 0.11 | 178.3 (0.5) | 178.1 (0.6) | 0.80 |
| Weight (kg) | 70.3 (1.0) | 74.3 (1.0) | 0.00 | 86.0 (0.8) | 85.1 (1.0) | 0.48 |
| BMI (kg/m2) | 25.8 (0.4) | 26.8 (0.3) | 0.04 | 27.0 (0.2) | 26.8 (0.3) | 0.60 |
| BSA (m2) | 1.79 (0.01) | 1.85 (0.01) | 0.00 | 2.06 (0.01) | 2.05 (0.01) | 0.44 |
| BIA estimates of whole body measurements | ||||||
| Lean mass (kg) | 45.5 (0.4) | 47.2 (0.4) | 0.00 | 63.6 (0.5) | 62.7 (0.6) | 0.24 |
| Fat mass (kg) | 24.8 (0.7) | 27.0 (0.7) | 0.04 | 22.3 (0.6) | 22.4 (0.6) | 0.96 |
| Percentage fat mass (%) | 34.5 (0.6) | 35.4 (0.6) | 0.22 | 25.5 (0.5) | 25.8 (0.5) | 0.69 |
| Appendicular lean massa (kg) | 20.2 (0.4) | 20.6 (0.3) | 0.27 | 25.6 (0.3) | 25.3 (0.4) | 0.56 |
| Relative appendicular lean mass† (kg/m2) | 7.4 (0.1) | 7.4 (0.1) | 0.71 | 8.0 (0.1) | 8.0 (0.1) | 0.74 |
| Handgrip strength (kg) | 28.8 (0.4) | 30.3 (0.4) | 0.01 | 47.5 (0.6) | 46.2 (0.7) | 0.15 |
Values are mean (SEM) unless otherwise stated
BMI body mass index, BSA body surface area, BIA bioimpedance analysis
aSum measurements of lean mass in all four limbs
bAppendicular lean mass adjusted for height (appendicular lean mass/height2)
Fig. 1Mean handgrip strength of the offspring vs. partners of the offspring according to gender-specific age tertiles. Age tertile (female)/(male), years: T1 = (39–59)/(45–62); T2 = (59–64)/(62–67); T3 = (64–79)/(67–83). Error bars indicate 95% confidence intervals
Multiple linear regression models showing the association between handgrip strength and offspring vs. partners of the offspring status
| Handgrip strength (kg) |
| ||
|---|---|---|---|
|
| SE | ||
| Model 1 | |||
| Offspring/partnersa | 0.00 | 0.49 | 0.994 |
| Age (years) | −0.44 | 0.04 | <0.001 |
| Genderb | 18.47 | 0.50 | <0.001 |
| Model 2 | |||
| Offspring/partners | 6.67 | 4.82 | 0.167 |
| Age (years) | −0.30 | 0.07 | <0.001 |
| Gender | 29.08 | 3.42 | <0.001 |
| Gender×age interaction | −0.17 | 0.05 | 0.002 |
| Offspring/partners×age interaction | −0.10 | 0.08 | 0.179 |
| Model 3 | |||
| Offspring/partners | 0.11 | 0.54 | 0.832 |
| Age (years) | −0.26 | 0.06 | <0.001 |
| Gender | 32.21 | 5.32 | <0.001 |
| Gender×age interaction | −0.25 | 0.08 | 0.003 |
| Body composition | |||
| Relative appendicular lean mass (kg/m2) | 0.44 | 0.20 | 0.030 |
| Whole body percentage fat mass (%) | −0.18 | 0.04 | <0.001 |
| Sum score of comorbidities | −0.67 | 0.45 | 0.136 |
| Sum score of medication categories | 0.55 | 0.37 | 0.139 |
| Thyroid function test, fT3 (pmol/l) | 0.17 | 0.40 | 0.675 |
| Current smoking | −0.92 | 0.82 | 0.267 |
| Excessive alcohol use | −0.32 | 0.68 | 0.639 |
B unstandardized regression coefficients, SE standard error
aOffspring = 0, partners = 1
bfemale = 0, male = 1